Ellevest’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Ellevest's CTKB Position: Q2 2023 in Review
Ellevest sold out of Cytek Biosciences (CTKB) in Q2 2023, closing a stake of 68 shares — an estimated $625 sold.
Ellevest first reported a position in CTKB in Q2 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 101 funds tracked by Wall St. Rank hold CTKB as of Q2 2023.
- Ellevest reported no remaining Cytek Biosciences position as of Q2 2023 after selling out during the quarter.
- Ellevest sold 68 Cytek Biosciences shares in Q2 2023, an estimated $625.
- Ellevest first reported a position in Cytek Biosciences in Q2 2022 and held it in 4 quarters.
- Ellevest's Cytek Biosciences position peaked at $2K in Q3 2022.
- 101 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2023.
Based on Ellevest's 13F filing for Q2 2023, filed 9 Aug 2023.